Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 4
2006 1
2007 1
2008 1
2009 2
2012 2
2013 3
2014 1
2015 3
2016 7
2017 6
2018 17
2019 23
2020 35
2021 34
2022 41
2023 32
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L; DeLLphi-301 Investigators. Ahn MJ, et al. N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20. N Engl J Med. 2023. PMID: 37861218 Clinical Trial.
A BRAF new world.
Frisone D, Friedlaender A, Malapelle U, Banna G, Addeo A. Frisone D, et al. Among authors: addeo a. Crit Rev Oncol Hematol. 2020 Aug;152:103008. doi: 10.1016/j.critrevonc.2020.103008. Epub 2020 May 26. Crit Rev Oncol Hematol. 2020. PMID: 32485528 Review.
Drugging KRAS: current perspectives and state-of-art review.
Parikh K, Banna G, Liu SV, Friedlaender A, Desai A, Subbiah V, Addeo A. Parikh K, et al. Among authors: addeo a. J Hematol Oncol. 2022 Oct 25;15(1):152. doi: 10.1186/s13045-022-01375-4. J Hematol Oncol. 2022. PMID: 36284306 Free PMC article. Review.
TMB or not TMB as a biomarker: That is the question.
Addeo A, Friedlaender A, Banna GL, Weiss GJ. Addeo A, et al. Crit Rev Oncol Hematol. 2021 Jul;163:103374. doi: 10.1016/j.critrevonc.2021.103374. Epub 2021 Jun 2. Crit Rev Oncol Hematol. 2021. PMID: 34087341 Review.
VISTA: A Promising Target for Cancer Immunotherapy?
Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M. Tagliamento M, et al. Among authors: addeo a. Immunotargets Ther. 2021 Jun 22;10:185-200. doi: 10.2147/ITT.S260429. eCollection 2021. Immunotargets Ther. 2021. PMID: 34189130 Free PMC article. Review.
Novel targets for immune-checkpoint inhibition in cancer.
Borgeaud M, Sandoval J, Obeid M, Banna G, Michielin O, Addeo A, Friedlaender A. Borgeaud M, et al. Among authors: addeo a. Cancer Treat Rev. 2023 Nov;120:102614. doi: 10.1016/j.ctrv.2023.102614. Epub 2023 Aug 12. Cancer Treat Rev. 2023. PMID: 37603905 Free article. Review.
212 results